• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素增强硼替佐米对人多发性骨髓瘤H929细胞的细胞毒性作用:NF-κB/JNK的潜在作用

Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: potential roles of NF-κB/JNK.

作者信息

Bai Qing-Xian, Zhang Xiao-Yan

机构信息

Department of Hematology, State Center of Bone Marrow Transplantation, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

出版信息

Int J Mol Sci. 2012;13(4):4831-4838. doi: 10.3390/ijms13044831. Epub 2012 Apr 16.

DOI:10.3390/ijms13044831
PMID:22606012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3344248/
Abstract

Combined curcumin and PS-341 treatment has been reported to enhance cytotoxicity and minimize adverse effects through ERK and p38MAPK mechanisms in human multiple myeloma cells. However, whether JNK plays similar role in this process remains unclear. In the present study, we found combined treatment altered NF-κB p65 expressions and distributions in multiple myeloma H929 cells. Western blot analysis showed combined treatment inactivated NF-κB while activated JNK signaling. Pre-treatment with JNK inhibitor SP600125 could attenuate NF-κB inactivation and restored H929 cells' survival. These results suggested that curcumin might enhance the cytotoxicity of PS-341 by interacting with NF-κB, at least in part, through JNK mechanism.

摘要

据报道,姜黄素与PS - 341联合治疗可通过ERK和p38MAPK机制增强人多发性骨髓瘤细胞的细胞毒性并将不良反应降至最低。然而,JNK在此过程中是否发挥类似作用仍不清楚。在本研究中,我们发现联合治疗改变了多发性骨髓瘤H929细胞中NF - κB p65的表达和分布。蛋白质印迹分析表明,联合治疗使NF - κB失活,同时激活JNK信号传导。用JNK抑制剂SP600125预处理可减弱NF - κB失活并恢复H929细胞的存活率。这些结果表明,姜黄素可能至少部分地通过JNK机制与NF - κB相互作用来增强PS - 341的细胞毒性。

相似文献

1
Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: potential roles of NF-κB/JNK.姜黄素增强硼替佐米对人多发性骨髓瘤H929细胞的细胞毒性作用:NF-κB/JNK的潜在作用
Int J Mol Sci. 2012;13(4):4831-4838. doi: 10.3390/ijms13044831. Epub 2012 Apr 16.
2
[Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism].姜黄素联合硼替佐米对人多发性骨髓瘤细胞系H929增殖及凋亡的影响及其机制
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):684-8.
3
Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells.硼替佐米增强了洛美沙星对人多发性骨髓瘤细胞的疗效。
Anticancer Drugs. 2013 Jul;24(6):609-16. doi: 10.1097/CAD.0b013e3283615006.
4
Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.靶向线粒体以克服多发性骨髓瘤(MM)细胞中的传统耐药性及硼替佐米/蛋白酶体抑制剂PS-341耐药性。
Blood. 2004 Oct 15;104(8):2458-66. doi: 10.1182/blood-2004-02-0547. Epub 2004 Jun 24.
5
Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling.蛋白酶体抑制剂PS-341通过JNK/c-Jun/AP-1信号通路诱导非小细胞肺癌细胞生长停滞和凋亡。
Cancer Sci. 2004 Feb;95(2):176-80. doi: 10.1111/j.1349-7006.2004.tb03200.x.
6
The NF-kappaB inhibitor LC-1 has single agent activity in multiple myeloma cells and synergizes with bortezomib.NF-κB 抑制剂 LC-1 在多发性骨髓瘤细胞中具有单药活性,并与硼替佐米协同作用。
Mol Cancer Ther. 2010 Jun;9(6):1574-82. doi: 10.1158/1535-7163.MCT-10-0104. Epub 2010 Jun 1.
7
The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.在响应蛋白酶体抑制剂硼替佐米而发生凋亡的人白血病细胞中,MAPK信号传导与活性氧生成之间的层级关系。
Exp Cell Res. 2004 May 1;295(2):555-66. doi: 10.1016/j.yexcr.2004.02.001.
8
Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.姜黄素与比卡鲁胺联合使用通过SAPK/JNK和MEK/ERK1/2介导的靶向NF-κB/p65和MUC1-C增强了对雄激素非依赖性前列腺癌细胞的生长抑制作用。
J Exp Clin Cancer Res. 2015 May 15;34(1):46. doi: 10.1186/s13046-015-0168-z.
9
Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs.新型姜黄素类似物使人类多发性骨髓瘤细胞对蛋白酶体抑制剂硼替佐米敏感。
Int J Mol Med. 2012 Jan;29(1):102-6. doi: 10.3892/ijmm.2011.814. Epub 2011 Oct 13.
10
[Effect of different concentrations of bortezomib on the expression of ERK, JNK and P38 in daunorubicin-resistant K562 cells].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):671-5.

引用本文的文献

1
Multiple myeloma inhibitory effects of natural compounds: enhancement through nanoparticle carriers.天然化合物对多发性骨髓瘤的抑制作用:通过纳米颗粒载体增强。
Front Pharmacol. 2025 Jun 17;16:1589090. doi: 10.3389/fphar.2025.1589090. eCollection 2025.
2
Curcumin in treatment of hematological cancers: Promises and challenges.姜黄素治疗血液系统癌症:前景与挑战
J Tradit Complement Med. 2024 Jan 5;14(2):121-134. doi: 10.1016/j.jtcme.2023.10.004. eCollection 2024 Mar.
3
Conceptualizing an Integrative Multiple Myeloma Care: The Role of Nutrition, Supplements, and Complementary Modalities.

本文引用的文献

1
BDMC33, A curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: role of inhibition in NF-κB and MAPK signaling pathways.姜黄素衍生物BDMC33在巨噬细胞样细胞系统中抑制炎症反应:对NF-κB和MAPK信号通路的抑制作用
Int J Mol Sci. 2012;13(3):2985-3008. doi: 10.3390/ijms13032985. Epub 2012 Mar 6.
2
Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs.新型姜黄素类似物使人类多发性骨髓瘤细胞对蛋白酶体抑制剂硼替佐米敏感。
Int J Mol Med. 2012 Jan;29(1):102-6. doi: 10.3892/ijmm.2011.814. Epub 2011 Oct 13.
3
Combining proteasome with cell cycle inhibitors: a dual attack potentially applicable to multiple hematopoietic malignancies.
概念化综合多发性骨髓瘤护理:营养、补充剂和补充疗法的作用。
Nutrients. 2024 Jan 11;16(2):237. doi: 10.3390/nu16020237.
4
A Review of The Synergistic Effects of Curcumin with Proteasome Inhibitors in Multiple Myeloma Preclinical Models.姜黄素与蛋白酶体抑制剂在多发性骨髓瘤临床前模型中的协同作用研究综述。
Integr Cancer Ther. 2023 Jan-Dec;22:15347354231159322. doi: 10.1177/15347354231159322.
5
Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma.蛋白激酶 D1 预测硼替佐米为基础的治疗反应不良和生存不良,其敲低增强多发性骨髓瘤对硼替佐米的药物敏感性。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820936770. doi: 10.1177/1533033820936770.
6
Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy.姜黄素在不耐受类固醇疗法的多发性骨髓瘤患者中的应用。
Clin Case Rep. 2020 Feb 25;8(4):739-744. doi: 10.1002/ccr3.2735. eCollection 2020 Apr.
7
Bortezomib-inducible long non-coding RNA myocardial infarction associated transcript is an oncogene in multiple myeloma that suppresses miR-29b.硼替佐米诱导的长非编码 RNA 心肌梗死相关转录物是多发性骨髓瘤中的一种癌基因,可抑制 miR-29b。
Cell Death Dis. 2019 Apr 9;10(4):319. doi: 10.1038/s41419-019-1551-z.
8
Intraclade Variability in Toxin Production and Cytotoxicity of Bacillus cereus Group Type Strains and Dairy-Associated Isolates.芽孢杆菌属群型菌株和乳制品相关分离株产毒株内变异性及细胞毒性。
Appl Environ Microbiol. 2018 Mar 1;84(6). doi: 10.1128/AEM.02479-17. Print 2018 Mar 15.
9
Curcumin and its analogue induce apoptosis in leukemia cells and have additive effects with bortezomib in cellular and xenograft models.姜黄素及其类似物可诱导白血病细胞凋亡,并且在细胞和异种移植模型中与硼替佐米具有协同作用。
Biomed Res Int. 2015;2015:968981. doi: 10.1155/2015/968981. Epub 2015 May 17.
10
Protective effect of Jiaweibugan decoction against diabetic peripheral neuropathy.加味补肝汤防治糖尿病周围神经病变的作用。
Neural Regen Res. 2013 Apr 25;8(12):1113-21. doi: 10.3969/j.issn.1673-5374.2013.12.006.
将蛋白酶体与细胞周期抑制剂相结合:一种可能适用于多种血液系统恶性肿瘤的双重攻击策略。
Expert Rev Hematol. 2011 Oct;4(5):483-6. doi: 10.1586/ehm.11.50.
4
[Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism].姜黄素联合硼替佐米对人多发性骨髓瘤细胞系H929增殖及凋亡的影响及其机制
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):684-8.
5
Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-κB and JNK/p38 MAPK activation pathways.竹节香附素通过抑制 NF-κB 和 JNK/p38 MAPK 激活通路抑制脂多糖介导的诱导型一氧化氮合酶和环氧化酶-2 的表达。
J Biomed Sci. 2011 May 6;18(1):28. doi: 10.1186/1423-0127-18-28.
6
MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling.MCP-1 诱导蛋白 1 去泛素化 TRAF 蛋白,负调控 JNK 和 NF-κB 信号通路。
J Exp Med. 2010 Dec 20;207(13):2959-73. doi: 10.1084/jem.20092641. Epub 2010 Nov 29.
7
Proteasome inhibitors in the treatment of multiple myeloma.蛋白酶体抑制剂在多发性骨髓瘤治疗中的应用
Leukemia. 2009 Nov;23(11):1964-79. doi: 10.1038/leu.2009.173. Epub 2009 Sep 10.
8
Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells.姜黄素与硼替佐米联用可协同诱导人多发性骨髓瘤U266细胞凋亡。
Mol Oncol. 2008 Dec;2(4):317-26. doi: 10.1016/j.molonc.2008.09.006. Epub 2008 Oct 7.
9
Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model.姜黄素在体外可克服化疗耐药性,并增强沙利度胺和硼替佐米对裸鼠模型中人类多发性骨髓瘤的治疗效果。
Mol Cancer Ther. 2009 Apr;8(4):959-70. doi: 10.1158/1535-7163.MCT-08-0905.
10
Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines.姜黄素可抑制核因子-κB的组成性激活,并且在伯基特淋巴瘤细胞系中诱导凋亡需要功能性Bax。
Mol Cancer Ther. 2008 Oct;7(10):3318-29. doi: 10.1158/1535-7163.MCT-08-0541.